amotosalen has been researched along with Acute Hemolytic Transfusion Reaction in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Anani, W; Bailey, SL; Benjamin, RJ; Cancelas, JA; Corash, L; Dumont, LJ; Erickson, AC; Genthe, JR; Mack, S; Mufti, N; Nestheide, S; Rugg, N; Schroeder, K; Shaz, B; Stolla, M; Szczepiorkowski, ZM; Yegneswaran, S | 1 |
| Benjamin, RJ; Bolliger, D; Buser, A; Corash, L; Holbro, A; Infanti, L; Irsch, J; Lin, JS; Merki, R; Passweg, J; Plattner, A; Tappe, D; Tsakiris, DA | 1 |
| Alandijany, TA; Azhar, EI; Bajrai, LH; Damanhouri, GA; El-Kafrawy, SA; Hassan, AM; Hindawi, SI; Tolah, AM | 1 |
| Benjamin, RJ; Bringmann, PW; Fadeyi, EA; Goldberg, C; Lu, T; Meier, NM; Namen, AM; Palavecino, E; Wagner, SJ; Young, P | 1 |
| Benjamin, RJ; Braschler, T; Corash, LM; Weingand, T | 1 |
| Herman, JH; Levy, JH; Neal, MD | 1 |
| Andreu, G; Boudjedir, K; Carlier, M; Drouet, C; Gachet, C; Gross, S; Kientz, D; Malard, L; Mertes, PM; Sandid, I; Tacquard, C | 1 |
| Benjamin, RJ; Corash, L; Huang, N; Koontz, C; Lam, CCK; Lee, CK; Leung, R; Lie, AKW; Liu, AY; Sim, J; Stassinopoulos, A; Tsoi, WC; Vermeij, HJ | 1 |
| Bardiaux, L; Deschaseaux, M; Morel, P; Naegelen, C | 1 |
| Benamara, H; Bost, V; Boussoulade, F; Chabre, C; Chavarin, P; Cognasse, F; Fabrigli, P; Garraud, O; Legrand, D; Odent-Malaure, H | 1 |
| Ciaravino, V; Cimino, G; McCullough, T; Sullivan, T | 1 |
| Allain, JP; Bianco, C; Blajchman, MA; Brecher, ME; Busch, M; Leiby, D; Lin, L; Stramer, S | 1 |
| McCullough, J | 1 |
4 review(s) available for amotosalen and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Bacterial contamination of platelets for transfusion: strategies for prevention.
Topics: Bacterial Load; Drug Contamination; Furocoumarins; Humans; Photosensitizing Agents; Platelet Transfusion; Transfusion Reaction; Ultraviolet Rays | 2018 |
[Prevention of bacterial risk: pathogen inactivation/detection of bacteria].
Topics: Automation; Bacteremia; Bacteria; Bacteriological Techniques; Blood; Blood Platelets; Blood Safety; Blood Transfusion; Blood-Borne Pathogens; Cross Infection; Disinfection; Equipment Contamination; France; Furocoumarins; Humans; Microbial Viability; Photochemistry; Photosensitizing Agents; Plasma; Risk Factors; Skin; Transfusion Reaction; Ultraviolet Rays | 2013 |
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
Topics: Anti-Infective Agents; Blood; Blood Banks; Blood Component Transfusion; Blood Transfusion; Blood-Borne Pathogens; Communicable Disease Control; Detergents; Furocoumarins; Humans; Infections; Methylene Blue; Photosensitizing Agents; Polyamines; Prions; Riboflavin; Risk; Solvents; Time Factors; Transfusion Reaction; Ultraviolet Rays | 2005 |
Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections.
Topics: Alkylating Agents; Anti-Infective Agents; Blood Banks; Blood Transfusion; Blood-Borne Pathogens; Communicable Disease Control; Detergents; Furocoumarins; Humans; Methylene Blue; Photosensitizing Agents; Randomized Controlled Trials as Topic; Riboflavin; Transfusion Reaction | 2007 |
9 other study(ies) available for amotosalen and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
Topics: Blood Platelets; Blood Preservation; Furocoumarins; Humans; Platelet Transfusion; Plateletpheresis; Thrombin; Thrombocytopenia; Transfusion Reaction; Ultraviolet Rays | 2022 |
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Platelets; Blood Safety; Child; Child, Preschool; Female; Furocoumarins; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Middle Aged; Platelet Transfusion; Retrospective Studies; Transfusion Reaction; Ultraviolet Rays; Young Adult | 2019 |
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
Topics: COVID-19; Furocoumarins; Humans; Plasma; SARS-CoV-2; Transfusion Reaction; Treatment Outcome; Ultraviolet Therapy; Virus Inactivation | 2021 |
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Blood Platelets; Blood-Borne Pathogens; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Equipment Failure; Fatal Outcome; Furocoumarins; Hip Fractures; Humans; Male; Middle Aged; Platelet Transfusion; Sepsis; Staphylococcal Infections; Staphylococcus saprophyticus; Thrombocytopenia; Transfusion Reaction; Ultraviolet Rays | 2021 |
Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
Topics: Bacterial Infections; Bacteriological Techniques; Blood Platelets; Blood Safety; Disinfection; Europe; Furocoumarins; Humans; Photosensitizing Agents; Transfusion Reaction; Ultraviolet Rays | 2017 |
Hypersensitivity transfusion reactions to platelet concentrate: a retrospective analysis of the French hemovigilance network.
Topics: Blood Platelets; Blood Transfusion; Furocoumarins; Humans; Platelet Transfusion; Retrospective Studies; Transfusion Reaction; Ultraviolet Rays | 2020 |
Transfusion of pathogen-reduced platelet components without leukoreduction.
Topics: Adult; Antisepsis; Blood Platelets; Blood-Borne Pathogens; Case-Control Studies; Cohort Studies; Disinfection; Female; Furocoumarins; Gamma Rays; Graft vs Host Disease; Humans; Leukocyte Count; Leukocytes; Male; Middle Aged; Platelet Transfusion; Transfusion Reaction; Ultraviolet Rays; Virus Inactivation | 2019 |
Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl-UVA (Intercept ™) over a 5-year period of extensive delivery.
Topics: Blood Preservation; Blood Transfusion; France; Furocoumarins; Humans; Hypersensitivity; Transfusion Reaction; Ultraviolet Rays | 2015 |
Preclinical safety profile of plasma prepared using the INTERCEPT Blood System.
Topics: Animals; Blood Specimen Collection; Blood Transfusion; Dermatitis, Phototoxic; Donor Selection; Female; Furocoumarins; Humans; In Vitro Techniques; Mice; Mutation; Neoplasms, Experimental; Photochemistry; Photosensitizing Agents; Plasma; Plasmapheresis; Pregnancy; Reproduction; Safety; Transfusion Reaction; Vasculitis | 2003 |